THE INTRODUCTION OF PRE-ENDOSCOPY (EGD) HIGH-DOSE INTRAVENOUS PROTON PUMP INHIBITION (HDIVPPI) IN THE MANAGEMENT OF PATIENTS WITH ACUTE UPPER GASTROINTESTINAL BLEEDING (UGIB) - A BUDGET IMPACT ANALYSIS
Author(s)
Barkun A1, Teich V2, Gralnek IM3, Bardou M4, Adam V51McGill University, Montreal, Quebec, Canada, 2MedInsight, Rio de Janeiro, Brazil, 3Rambam Health Care Campus, Haifa, Israel, 4University of Burgundy, Dijon, Bourgogne, France, 5McGill University , Montreal, QC, Canada
OBJECTIVES To quantify the budget impact of using HDIVPPI before EGD in ambulatory patients presenting with acute, overt UGIB in different clinical scenarios. METHODS A decision tree compared pre-EGD HDIVPPI to none in a model that emulates contemporary standards of care. Patients were stratified by clinical likelihood of rebleeding (high/low), time to EGD, method of endoscopic hemostasis (epinephrine injection/other), and early discharge when clean-base ulcers are noted (frequent/rare). Probabilities and lengths of stay originated from the literature and bleeding registries. Hospital and additional pharmacological costs came from the Nationwide Inpatient Sample and Red Book (2008 $US). Expert consensus was sought when needed. Esomeprazole was the PPI in the base-case. One-way deterministic sensitivity analyses were performed on all variables across wide pre-set ranges. Model time horizon was 30 days, adopting a third-party payer perspective. RESULTS In the base-case, average costs were $9139 for the pre-EGD HDIVPPI strategy and $9029 for the arm without. This increment rose slightly amongst patients with a high clinical likelihood of rebleeding ($117/pt) or when using only hemostatic methods other than epinephrine injection ($128/pt). It dropped amongst patients undergoing epinephrine injection ($95/pt) or a late EGD ($37/pt). All mean costs were lowest, and this time favoring the HDIVPPI approach, when clean-base ulcer patients were discharged early ($8,263 for HDIVPPI versus $8,282 for none).In sensitivity analyses, variables with the greatest impact were the per diem cost of hospital stay complicated by rebleeding, and elapsed times to early or late EGD; overall per patient incremental costs varied from $16-$174. CONCLUSIONS The introduction of HDIVPPI prior to EGD in a US managed care setting amongst acute UGIB patients in most scenarios raise modestly mean patient costs. This approach, however, becomes cheaper than no PPI administration pre-EGD when selected patients bleeding from clean-base ulcers are discharged home from the emergency room.
Conference/Value in Health Info
2009-09, ISPOR Latin America 2009, Rio de Janeiro, Brazil
Value in Health, Vol. 12, No. 7 (October 2009)
Code
CS6
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
Gastrointestinal Disorders